95 related articles for article (PubMed ID: 18230052)
21. Medulloblastoma growth inhibition by hedgehog pathway blockade.
Berman DM; Karhadkar SS; Hallahan AR; Pritchard JI; Eberhart CG; Watkins DN; Chen JK; Cooper MK; Taipale J; Olson JM; Beachy PA
Science; 2002 Aug; 297(5586):1559-61. PubMed ID: 12202832
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of inhibitors of Hedgehog signaling based on the alkaloid cyclopamine.
Winkler JD; Isaacs A; Holderbaum L; Tatard V; Dahmane N
Org Lett; 2009 Jul; 11(13):2824-7. PubMed ID: 19552464
[TBL] [Abstract][Full Text] [Related]
23. [The role of chemotherapy in pediatric medulloblastoma].
Schuler D
Magy Onkol; 2010 Jun; 54(2):145-52. PubMed ID: 20576591
[TBL] [Abstract][Full Text] [Related]
24. Paracrine Hedgehog signaling in cancer.
Theunissen JW; de Sauvage FJ
Cancer Res; 2009 Aug; 69(15):6007-10. PubMed ID: 19638582
[TBL] [Abstract][Full Text] [Related]
25. GDC-0449-a potent inhibitor of the hedgehog pathway.
Robarge KD; Brunton SA; Castanedo GM; Cui Y; Dina MS; Goldsmith R; Gould SE; Guichert O; Gunzner JL; Halladay J; Jia W; Khojasteh C; Koehler MF; Kotkow K; La H; Lalonde RL; Lau K; Lee L; Marshall D; Marsters JC; Murray LJ; Qian C; Rubin LL; Salphati L; Stanley MS; Stibbard JH; Sutherlin DP; Ubhayaker S; Wang S; Wong S; Xie M
Bioorg Med Chem Lett; 2009 Oct; 19(19):5576-81. PubMed ID: 19716296
[TBL] [Abstract][Full Text] [Related]
26. Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma.
Kim W; Yoon JH; Kim JR; Jang IJ; Bang YJ; Kim YJ; Lee HS
Cancer Chemother Pharmacol; 2009 Aug; 64(3):497-507. PubMed ID: 19096848
[TBL] [Abstract][Full Text] [Related]
27. Statins repress hedgehog signaling in medulloblastoma with no bone toxicities.
Fan Q; Gong T; Zheng C; Ng JMY; Chen J; Myers C; Hensley H; Curran T; Yang ZJ
Oncogene; 2021 Mar; 40(12):2258-2272. PubMed ID: 33649536
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in the design of Hedgehog pathway inhibitors for the treatment of malignancies.
Banerjee U; Hadden MK
Expert Opin Drug Discov; 2014 Jul; 9(7):751-71. PubMed ID: 24850423
[TBL] [Abstract][Full Text] [Related]
29. Pathological and molecular heterogeneity of medulloblastoma.
Gulino A; Arcella A; Giangaspero F
Curr Opin Oncol; 2008 Nov; 20(6):668-75. PubMed ID: 18841049
[TBL] [Abstract][Full Text] [Related]
30. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N
Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881
[TBL] [Abstract][Full Text] [Related]
31. Development of a monoclonal antibody-based ELISA for the hedgehog inhibitors cyclopamine and KAAD-cyclopamine.
Lee ST; Panter KE; Gardner DR; Green BT; Welch KD; Zhang J; Chang CW
J Pharm Biomed Anal; 2012 Jul; 66():282-6. PubMed ID: 22516681
[TBL] [Abstract][Full Text] [Related]
32. Cathepsin B is a target of Hedgehog signaling in pancreatic cancer.
Hwang JH; Lee SH; Lee KH; Lee KY; Kim H; Ryu JK; Yoon YB; Kim YT
Cancer Lett; 2009 Jan; 273(2):266-72. PubMed ID: 19004543
[TBL] [Abstract][Full Text] [Related]
33. Recent development in chemotherapy of paediatric brain tumours.
Grill J; Bhangoo R
Curr Opin Oncol; 2007 Nov; 19(6):612-5. PubMed ID: 17906461
[TBL] [Abstract][Full Text] [Related]
34. Statins activate a mitochondria-operated pathway of apoptosis in breast tumor cells by a mechanism regulated by ErbB2 and dependent on the prenylation of proteins.
Herrero-Martin G; López-Rivas A
FEBS Lett; 2008 Jul; 582(17):2589-94. PubMed ID: 18582466
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of cyclopamine using a biomimetic and diastereoselective approach.
Giannis A; Heretsch P; Sarli V; Stössel A
Angew Chem Int Ed Engl; 2009; 48(42):7911-4. PubMed ID: 19591183
[No Abstract] [Full Text] [Related]
36. Synthesis and anticancer activity studies of cyclopamine derivatives.
Zhang J; Garrossian M; Gardner D; Garrossian A; Chang YT; Kim YK; Chang CW
Bioorg Med Chem Lett; 2008 Feb; 18(4):1359-63. PubMed ID: 18221872
[TBL] [Abstract][Full Text] [Related]
37. Expression of MAGE and GAGE genes in medulloblastoma and modulation of resistance to chemotherapy. Laboratory investigation.
Kasuga C; Nakahara Y; Ueda S; Hawkins C; Taylor MD; Smith CA; Rutka JT
J Neurosurg Pediatr; 2008 Apr; 1(4):305-13. PubMed ID: 18377306
[TBL] [Abstract][Full Text] [Related]
38. Depletion of the colonic epithelial precursor cell compartment upon conditional activation of the hedgehog pathway.
van Dop WA; Uhmann A; Wijgerde M; Sleddens-Linkels E; Heijmans J; Offerhaus GJ; van den Bergh Weerman MA; Boeckxstaens GE; Hommes DW; Hardwick JC; Hahn H; van den Brink GR
Gastroenterology; 2009 Jun; 136(7):2195-2203.e1-7. PubMed ID: 19272384
[TBL] [Abstract][Full Text] [Related]
39. The Hedgehog signalling pathway as a therapeutic target in early breast cancer development.
O'Toole SA; Swarbrick A; Sutherland RL
Expert Opin Ther Targets; 2009 Sep; 13(9):1095-103. PubMed ID: 19659449
[TBL] [Abstract][Full Text] [Related]
40. Second generation 2-pyridyl biphenyl amide inhibitors of the hedgehog pathway.
Castanedo GM; Wang S; Robarge KD; Blackwood E; Burdick D; Chang C; Dijkgraaf GJ; Gould S; Gunzner J; Guichert O; Halladay J; Khojasteh C; Lee L; Marsters JC; Murray L; Peterson D; Plise E; Salphati L; de Sauvage FJ; Wong S; Sutherlin DP
Bioorg Med Chem Lett; 2010 Nov; 20(22):6748-53. PubMed ID: 20875741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
